Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00458159. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00045305. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously T
ClinicalTrials.gov study NCT03146871. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT04419649. IPD Sharing: YES. Countries: 8. Publications: 0.
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
ClinicalTrials.gov study NCT00322101. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01444742. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT05568225. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02145026. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00831766. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00414310. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transpla
ClinicalTrials.gov study NCT01995578. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02469415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00469144. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00503880. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01379274. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00569010. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02014051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Flotetuzumab for Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)
ClinicalTrials.gov study NCT04582864. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00656617. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation
ClinicalTrials.gov study NCT01891968. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.